I
Instituto Oncologico de Cordoba | Cordoba, Argentina
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Nivolumab
BMS-936558
Pembrolizumab
Erlotinib
Docetaxel
Ipilimumab
Afatinib
Vedotin
NPI-2358
Everolimus
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 7 total trials
Locations recently updated
This study is being done to see if a drug called disitamab vedotin, alone or with pembrolizumab, works to treat HER2 expressing urothelial cancer. It...
Enrolling
Urothelial Carcinoma
Drug: pembrolizumab
Drug: disitamab vedotin
Trial sponsors
N
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems